The science of pharmaceutical compounding

Non-Sterile Compounding Training

 

Overview

 

Pharmacists and Technicians who complete this practice-based compounding program will be able to extemporaneously prepare viable pharmaco-therapeutic non-sterile dosage forms, having given ample consideration to such issues as medical necessity, patient specific need, and legal and regulatory guidelines in consultation with a prescriber. Practical and technical skill development is equally learned in a compounding laboratory environment where the pharmacist and technician will be trained in all aspects of non-sterile preparatory procedures. Pharmacists will also become well versed in the requirements to set up a business development marketing plan.

 

Key Benefits and Takeaways

 

§          A healthy balance between didactic and practical hands-on training

§          A highly relevant experience for today’s compounding pharmacist

§          Focused on the most frequently compounded dosage forms

§          Each day hosts specialty niche market presentations

    

Who Should Attend

 

This practice-based program, with its broad range of core competencies in pharmaceutical compounding, is well suited for:

 

§          Both the newly practicing and experienced pharmacist who wishes to complement their business and   establish a compounding practice for the first time;

§          The experienced compounding pharmacist who wishes to gain a more in-depth understanding of the clinical, pharmacological and preparatory procedures involved in the decision-making process in compounding;

§          The expert compounding pharmacist wishing to take a refresher course so as to demonstrate core competencies in this field of expertise.

 

Program in Detail

 

This is a 48 hour practice-based program; 24 hour self-study course and a 24 hour live course. This program is intended to provide the pharmacist with focused training in non-sterile compounding through the application of adult education principles of learning.

 

The self-study course includes:

 

§          A learning assessment encompassing all twelve modules and will serve as the examination process for the self-study course;

§          The self-study examination process will not only ensure a theoretical competency level, but is a pre-curser to the live course and is intended to facilitate a higher level of learning in the live course;

§          Each module contains randomized and identifiable questions requiring more broad thinking or concept generation affording the pharmacist the opportunity to reflect on some of the more prominent issues in a contemporary compounding practice;

§          Questions the participant needs answer to appropriately address various issues. These questions also engage the reader during the self-study learning process.

 

         The 3-day live course contains:

 

§        A healthy balance between classroom sessions and practical hands-on compounding; twelve hours each;

§          Classroom sessions are composed of a careful mix of didactic and interactive learning.  Participants will have the opportunity to assess their skills as the live course progresses;

§          Most frequently compounded dosage forms representative of 90% of what today’s compounding pharmacist prepares in their day-to-day practice;

§          Current practice tips for three prominent niche markets; hormone replacement; pain management and veterinary compounding. Each of these sessions is divided into three key components; pharmaceutics, clinical practice tips and administrative tools;

§          Informatics (reference materials and Internet resources), marketing insights and tips, and compounding law round-out the itinerary;

§         Case scenarios during problem-solving sessions. All previously learned program material will be used to solve these cases.

 

Planning Committee and Program Reviewers

 

Joe Cabaleiro, BS :	Consultant, MEDISCA Network; Compounding Pharmacist, Triangle Pharmacy; Auditor & Consultant, PCAB; Cary, NC
Judy Riffee, RPh, BS Pharm :	Consultant, MEDISCA Network; Dev. Coord., Office of Interdisc Ed, Office VP for Health Affairs, University of Florida; Gainesville, FL
Kelli Hosey, BS; RPh :	Consultant, MEDISCA Network; Coordinator IV Therapy, ShandsHospital; Gainesville, FL
Ken Speidel, PharmD :	Consultant, MEDISCA Network; Assoc. Prof., University of Findlay, College of Pharmacy; Auditor & Consultant, PCAB; Ravenna, OH
Kenneth Latta, BS; RPh :	Consultant, MEDISCA Network; Compounding Pharmacist, Duke University; Auditor & Consultant, PCAB; Durham, NC
Kerry Earlywine, PharmD :	Compounding Pharmacist & Technical Support Services Consultant, MEDISCA Network
Mark Filosi, BS Pharm :	Consultant, MEDISCA Network; Compounding Pharmacist, Family Care Pharmacy; Tampa, FL
Steve Gillis, PharmD :	Pharmacist, ShandsHospitalCancerCenter; Gainesville, FL
Tim Klahs, MBA :	BA Mathematics; MBA Finance; Independent Financial Consultant; Tampa, FL
Vanessa Pinheiro, BS, MSc :	Compounding Pharmacist & Technical Support Services Consultant, MEDISCA Network

 

Declarations and Disclosures

 

The University of Florida College of Pharmacy believes it is important for the reader to be aware of relevant affiliations and financial relationships regarding the development, design and facilitation of this program and its financial supporter and the financial supporter’s affiliates.

 

Disclaimer

 

MEDISCA Network Inc is an independent corporation and has an established agreement with The MEDISCA Group of Companies ensuring all other companies under the umbrella of The MEDISCA Group of Companies have no influence on MEDISCA Network Inc as it relates to program offerings. As such, this program has been developed and hosted by the University of Florida College of Pharmacy and is therefore absent of any bias, prejudice or commercialism. MEDISCA Network Inc has been asked by the University of Florida College of Pharmacy to market this program.

 

Accreditation and Program Continuing Education Credits

This program is accredited by the University of Florida College of Pharmacy in accordance with ACPE Standards for Quality and Interpretive Guidelines. The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

The program number for this practice-based CPE activity is 0012-0000-09-218-L04-P. The University of Florida College of Pharmacy has allocated 16 contact hours (1.6 credits) to this 2-day live program. Its release date is April 6, 2010. The program accreditation expires March 5, 2012. A statement of credit will be issued to the program participant within 30 days of the program’s completion.